FDA Inspection 1008395 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1000221279

The FDA completed an inspection of American Red Cross Blood Services on April 10, 2017 in Scranton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 10, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Scranton, PA (United States)